ATE209490T1 - Substanz p antagonisten zur behandlung von erbrechen - Google Patents
Substanz p antagonisten zur behandlung von erbrechenInfo
- Publication number
- ATE209490T1 ATE209490T1 AT94303467T AT94303467T ATE209490T1 AT E209490 T1 ATE209490 T1 AT E209490T1 AT 94303467 T AT94303467 T AT 94303467T AT 94303467 T AT94303467 T AT 94303467T AT E209490 T1 ATE209490 T1 AT E209490T1
- Authority
- AT
- Austria
- Prior art keywords
- vomiting
- antagonists
- substance
- treatment
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/072,629 US5393762A (en) | 1993-06-04 | 1993-06-04 | Pharmaceutical agents for treatment of emesis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209490T1 true ATE209490T1 (de) | 2001-12-15 |
Family
ID=22108825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94303467T ATE209490T1 (de) | 1993-06-04 | 1994-05-16 | Substanz p antagonisten zur behandlung von erbrechen |
Country Status (19)
Country | Link |
---|---|
US (1) | US5393762A (de) |
EP (1) | EP0627221B1 (de) |
JP (1) | JP2671972B2 (de) |
KR (1) | KR100190729B1 (de) |
CN (1) | CN1100535C (de) |
AT (1) | ATE209490T1 (de) |
AU (1) | AU666077B2 (de) |
CA (1) | CA2124990C (de) |
DE (1) | DE69429208T2 (de) |
DK (1) | DK0627221T3 (de) |
ES (1) | ES2164088T3 (de) |
HU (1) | HU222243B1 (de) |
IL (1) | IL109802A (de) |
MY (1) | MY115310A (de) |
NZ (1) | NZ260674A (de) |
PT (1) | PT627221E (de) |
RU (1) | RU2135179C1 (de) |
TW (1) | TW318791B (de) |
ZA (1) | ZA943896B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL171379B1 (en) * | 1991-05-31 | 1997-04-30 | Pfizer | Method of obtaining novel derivatives of quinuclidine |
ATE142199T1 (de) * | 1991-06-20 | 1996-09-15 | Pfizer | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
EP0916346A3 (de) | 1991-09-20 | 2000-12-06 | Glaxo Group Limited | NK-1 Rezeptor Antagonisten und 5HT3 Rezeptor Antagonisten zur Behandlung von Emesis |
US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
CA2157117C (en) * | 1993-03-04 | 1999-01-05 | Manoj C. Desai | Spirocyclic piperidine derivatives |
GB9305718D0 (en) | 1993-03-19 | 1993-05-05 | Glaxo Group Ltd | Medicaments |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
KR19980703354A (ko) * | 1995-03-27 | 1998-10-15 | 나카토미히로타카 | 피페리딘 유도체 |
TW340842B (en) | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
TW458774B (en) * | 1995-10-20 | 2001-10-11 | Pfizer | Antiemetic pharmaceutical compositions |
US6329396B1 (en) | 1996-06-10 | 2001-12-11 | Pfizer Inc. | Substituted benzylaminopiperidine compounds |
GB9708484D0 (en) | 1997-04-25 | 1997-06-18 | Merck Sharp & Dohme | Therapeutic agents |
US6214846B1 (en) * | 1997-06-27 | 2001-04-10 | Merck Sharp & Dohme Limited | Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
AU1409100A (en) * | 1998-11-27 | 2000-06-19 | Takeda Chemical Industries Ltd. | Drugs |
IL133077A0 (en) * | 1999-01-29 | 2001-03-19 | Pfizer Prod Inc | Azithromycin combination for emesis control in dogs |
US6255320B1 (en) * | 1999-06-01 | 2001-07-03 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
US6387925B1 (en) * | 1999-06-01 | 2002-05-14 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions |
US6262067B1 (en) * | 1999-06-22 | 2001-07-17 | Pfizer Inc. | Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
IL142810A0 (en) * | 2000-05-03 | 2002-03-10 | Pfizer Prod Inc | Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
EP1411946A1 (de) * | 2001-07-20 | 2004-04-28 | Pfizer Products Inc. | Verwendung von nk-1 rezeptor antagonisten zur beeinflussung unerwünschten verhaltens bei hunden, katzen und pferden |
US8183230B2 (en) * | 2004-01-30 | 2012-05-22 | Pfizer Inc. | Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
MXPA06007964A (es) * | 2004-01-30 | 2007-01-26 | Pfizer Prod Inc | Antagonistas del receptor nk-1 para mejorar la recuperacion de anestesia. |
DE602005003791T2 (de) * | 2004-02-02 | 2008-05-29 | Pfizer Products Inc., Groton | Verfahren zur herstellung von 1-(2s,3s)-2-benzhydril-n-(5-tert.-butyl-2-methoxybenzyl)chinuklidin-3-amin |
WO2014197137A1 (en) * | 2013-04-29 | 2014-12-11 | Howard Brooks-Korn | Diversion-resistant formulation |
WO2018175670A1 (en) | 2017-03-22 | 2018-09-27 | The Research Foundation For The State University Of New York | Matrix metalloproteinase-9 hemopexin domain inhibitors and methods of treatment using same |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
WO1990005525A1 (en) * | 1988-11-23 | 1990-05-31 | Pfizer Inc. | Quinuclidine derivatives as substance p antagonists |
US5232929A (en) * | 1990-11-28 | 1993-08-03 | Pfizer Inc. | 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use |
AU648317B2 (en) * | 1990-06-01 | 1994-04-21 | Pfizer Inc. | 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them |
DK0540526T3 (da) * | 1990-07-23 | 1995-04-18 | Pfizer | Quinuclidinderivater |
ATE121389T1 (de) * | 1990-09-28 | 1995-05-15 | Pfizer | Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen. |
EP0566589A1 (de) * | 1991-01-10 | 1993-10-27 | Pfizer Inc. | N-alkyl chinuclidiniumsalze als substanz-p-antagoniste |
ES2065175T3 (es) * | 1991-03-01 | 1995-02-01 | Pfizer | Derivados de 1-azabiciclo(3.2.2)nonan-3-amina. |
CA2106200C (en) * | 1991-03-26 | 1996-11-19 | Terry J. Rosen | Stereoselective preparation of substituted piperidines |
PL170513B1 (en) * | 1991-05-22 | 1996-12-31 | Pfizer | Method of obtaining novel derivatives of 3-amino quinuclidine |
PL171379B1 (en) * | 1991-05-31 | 1997-04-30 | Pfizer | Method of obtaining novel derivatives of quinuclidine |
ATE142199T1 (de) * | 1991-06-20 | 1996-09-15 | Pfizer | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen |
TW202432B (de) * | 1991-06-21 | 1993-03-21 | Pfizer | |
EP0916346A3 (de) * | 1991-09-20 | 2000-12-06 | Glaxo Group Limited | NK-1 Rezeptor Antagonisten und 5HT3 Rezeptor Antagonisten zur Behandlung von Emesis |
HU9400728D0 (en) * | 1991-09-26 | 1994-06-28 | Pfizer | Fused tricyclic nitrogen containing heterocycles as substance p receptor antagonists |
EP0613458B1 (de) * | 1991-11-12 | 1998-01-07 | Pfizer Inc. | Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten |
JP2656702B2 (ja) * | 1992-03-23 | 1997-09-24 | ファイザー製薬株式会社 | ペプチド性キヌクリジン |
EP0641328B1 (de) * | 1992-05-18 | 2001-11-21 | Pfizer Inc. | Überbrückte azabicyclische derivate als substanz p antagonisten |
PT675886E (pt) * | 1992-12-10 | 2000-12-29 | Pfizer | Heterociclos nao aromaticos com substituintes aminometileno e sua utilizacao como antagonistas da substancia p |
CA2157117C (en) * | 1993-03-04 | 1999-01-05 | Manoj C. Desai | Spirocyclic piperidine derivatives |
GB9305718D0 (en) * | 1993-03-19 | 1993-05-05 | Glaxo Group Ltd | Medicaments |
WO2000010073A1 (en) * | 1998-08-14 | 2000-02-24 | Via, Inc. | Mobile robotic snake |
-
1993
- 1993-06-04 US US08/072,629 patent/US5393762A/en not_active Expired - Lifetime
-
1994
- 1994-04-12 TW TW083103232A patent/TW318791B/zh active
- 1994-05-16 AT AT94303467T patent/ATE209490T1/de not_active IP Right Cessation
- 1994-05-16 ES ES94303467T patent/ES2164088T3/es not_active Expired - Lifetime
- 1994-05-16 PT PT94303467T patent/PT627221E/pt unknown
- 1994-05-16 DE DE69429208T patent/DE69429208T2/de not_active Expired - Fee Related
- 1994-05-16 EP EP94303467A patent/EP0627221B1/de not_active Expired - Lifetime
- 1994-05-16 DK DK94303467T patent/DK0627221T3/da active
- 1994-05-26 IL IL10980294A patent/IL109802A/en not_active IP Right Cessation
- 1994-06-02 MY MYPI94001422A patent/MY115310A/en unknown
- 1994-06-02 CA CA002124990A patent/CA2124990C/en not_active Expired - Fee Related
- 1994-06-02 JP JP6121042A patent/JP2671972B2/ja not_active Expired - Fee Related
- 1994-06-03 NZ NZ260674A patent/NZ260674A/en not_active IP Right Cessation
- 1994-06-03 CN CN94106917A patent/CN1100535C/zh not_active Expired - Fee Related
- 1994-06-03 HU HU9401676A patent/HU222243B1/hu not_active IP Right Cessation
- 1994-06-03 KR KR1019940012527A patent/KR100190729B1/ko not_active IP Right Cessation
- 1994-06-03 AU AU64521/94A patent/AU666077B2/en not_active Ceased
- 1994-06-03 ZA ZA943896A patent/ZA943896B/xx unknown
- 1994-06-03 RU RU94020410A patent/RU2135179C1/ru not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0627221A2 (de) | 1994-12-07 |
EP0627221A3 (de) | 1995-08-02 |
HU9401676D0 (en) | 1994-09-28 |
PT627221E (pt) | 2002-04-29 |
AU6452194A (en) | 1994-12-15 |
JP2671972B2 (ja) | 1997-11-05 |
CN1121806A (zh) | 1996-05-08 |
IL109802A (en) | 2002-04-21 |
KR100190729B1 (ko) | 1999-06-01 |
NZ260674A (en) | 2000-07-28 |
IL109802A0 (en) | 1994-08-26 |
ES2164088T3 (es) | 2002-02-16 |
HUT71550A (en) | 1995-12-28 |
ZA943896B (en) | 1995-12-04 |
DE69429208D1 (de) | 2002-01-10 |
EP0627221B1 (de) | 2001-11-28 |
DK0627221T3 (da) | 2002-02-11 |
JPH0753362A (ja) | 1995-02-28 |
RU94020410A (ru) | 1996-05-10 |
TW318791B (de) | 1997-11-01 |
MY115310A (en) | 2003-05-31 |
KR950000144A (ko) | 1995-01-03 |
US5393762A (en) | 1995-02-28 |
DE69429208T2 (de) | 2002-05-23 |
AU666077B2 (en) | 1996-01-25 |
HU222243B1 (hu) | 2003-05-28 |
CA2124990C (en) | 1999-04-20 |
CN1100535C (zh) | 2003-02-05 |
RU2135179C1 (ru) | 1999-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209490T1 (de) | Substanz p antagonisten zur behandlung von erbrechen | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
DE69429299D1 (de) | Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen | |
GB9406857D0 (en) | Improvements in or relating to organic compounds | |
MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
ES2104358T3 (es) | Inhibidores sililados de acetilcolinesterasa. | |
DE69710111D1 (de) | Behandlung und Prophylaxe von Pankreatitis | |
ATE259818T1 (de) | Substituierte tricyclische verbindungen und deren verwendung zur behandlung von spla2-bedingten erkrankungen | |
DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
DE69412178D1 (de) | Apparat zur Behandlung von Lagen | |
DE59100861D1 (de) | Kontinue-verfahren zur behandlung von textilen warenbahnen und entsprechende anlage. | |
ES2150418T3 (es) | Composiciones farmaceuticas que comprenden calcitonina. | |
DE68908986D1 (de) | Behandlung von mit organischen Verbindungen verunreinigten anorganischen Salzen. | |
DE59410340D1 (de) | Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen | |
ATE178336T1 (de) | Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |